NCT06319755

Brief Summary

The goal of this observational study is to learn about intestinal microbiome structure and function in individuals who have undergone a pancreatoduodenectomy and compare to healthy matched controls. The primary objectives of the study are:

  • Three-day food, bowel and medication diary (see Protocol appendix 5)
  • Gastrointestinal Symptom Rating Scale (see Protocol appendix 6)
  • Quality of life questionnaire (see Protocol appendix 7)
  • Stool sample test using Microba Insight TradeMark (a small swab is taken from soiled toilet paper, sealed in a room-temperature storage capsule and mailed to the testing laboratory)

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 6, 2024

Completed
14 days until next milestone

First Posted

Study publicly available on registry

March 20, 2024

Completed
4 months until next milestone

Study Start

First participant enrolled

August 1, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2025

Completed
Last Updated

July 24, 2025

Status Verified

July 1, 2024

Enrollment Period

1 year

First QC Date

March 6, 2024

Last Update Submit

July 21, 2025

Conditions

Keywords

matched case control study

Outcome Measures

Primary Outcomes (1)

  • Comparison of microbiota profile between post-surgical participants and healthy controls.

    Stool samples will be analysed to compare the Shannon diversity index (calculated by taking the number of each microbial species, the proportion each species is of the total number of individuals, summed by the proportion times the natural log of the proportion for each species) between participant groups.

    During data collection, 3 days

Secondary Outcomes (6)

  • Compliance with 3-day food dairies

    From enrollment to the collection of data from participants, 3 days

  • Pre-paid return rates

    From enrollment to the collection of data from participants, 3 days

  • Ease of matching

    Enrollment period, up to 12 months

  • Shannon diversity index

    During data collection period, 3 days

  • Gastrointestinal symptoms

    During data collection period, 3 days

  • +1 more secondary outcomes

Study Arms (2)

Post-surgical patients

Adults having had pancreatoduodenectomy (Whipple's) surgery for curative intent.

Matched controls

Participants matched to each post-surgical participant by age, sex, body mass index (BMI), smoking status.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Post-surgical patients are adults (aged ≥ 18 years) who have undergone a pancreatoduodenectomy (Whipple's) surgery for curative between the time period of April 2018 - December 2023, and received post-operative clinical management at Royal Prince Alfred Hospital. Healthy adults (matched controls) will be matched by age, sex, body mass index and smoking status.

You may qualify if:

  • Adults (aged equal to or greater than 18 years) having had pancreatoduodenectomy (Whipple's) surgery between April 2018 - December 2023 for curative intent and received post-operative clinical management at Royal Prince Alfred Hospital, (post-surgical participants), and
  • Healthy adults matched by age, sex, body mass index and smoking status

You may not qualify if:

  • Aged less than 18 years
  • Are unable to complete the questionnaires or testing due to language or cognitive limitations
  • Have active or recurring pancreatic cancer, or where the surgery was for non-curative intent
  • Have other gastrointestinal conditions that could affect gut symptoms or microbiome such as Inflammatory Bowel disease, Irritable Bowel Syndrome Coeliac disease, or are currently pregnant or breastfeeding
  • Are currently taking medications or diet that can affect gut symptoms or microbiome

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Nutrition and Dietetics, Royal Prince Alfred Hospital

Camperdown, New South Wales, 2050, Australia

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

Stool samples

MeSH Terms

Conditions

Pancreatic Neoplasms

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsEndocrine Gland NeoplasmsDigestive System DiseasesPancreatic DiseasesEndocrine System Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Dietitian

Study Record Dates

First Submitted

March 6, 2024

First Posted

March 20, 2024

Study Start

August 1, 2024

Primary Completion

August 1, 2025

Study Completion

August 1, 2025

Last Updated

July 24, 2025

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations